This network meta-analysis aims to investigate the efficacy of anti-PD-1- <i>vs</i> anti-PD-L1-based therapy in R/M HNSCC cancer patients through a systematic review of the literature to provide support for evidence-based treatment decisions. Here, CD274 is linked to head and neck squamous cell carcinoma.